Sawai Group Web Accessibility Policy
To ensure that websites operated by Sawai Group companies are accessible to everyone, including seniors and people with disabilities, we strive to meet the WCAG (Web Content Accessibility Guidelines) conformance level AA standards set by the World Wide Web Consortium.
1. Scope
Websites operated by Sawai Group companies
- https://www.sawaigroup.holdings/Opens in a new window.
- https://global.sawaigroup.holdings/
- https://www.sawai.co.jp/Opens in a new window.
- https://global.sawai.co.jp/Opens in a new window.
- https://med.sawai.co.jp/Opens in a new window.
- https://kenko.sawai.co.jp/Opens in a new window.
- https://genechan.sawai.co.jp/Opens in a new window.
- https://www.medisa.co.jp/Opens in a new window.
- https://www.kakenshoyaku.com/Opens in a new window.
- https://www.trustpharmatech.co.jp/Opens in a new window.
- https://zutsu-online.jp/Opens in a new window.
- https://大人の神経発達症.jp/Opens in a new window.
- https://www.sawai-lenalidomide.jp/Opens in a new window.
Testing will be conducted and results published on a Web page-by-Web page basis.
2. Target Conformance Level and Degree of Compatibility
Compliant with W3C WCAG 2.1 conformance level AA
Note: The term “compliant” in this Web Accessibility Policy is based on the terminology defined in the “JIS X 8341-3:2016 Guidelines for Indicating Degree of Compatibility for Web Content - April 2021 Edition” by the Web Accessibility Infrastructure Committee of the Info-Communications Access Council.
Given the intent of the website, “大人の神経発達症.jp” (AdultNeurodevelopmentalDisorders.jp) is already aiming for WCAG2.2 conformance level AA.
3. Compliance Timeline and Deadline for Goal Achievement
| June 2024 | Confirmation of WCAG2.1 conformance |
|---|---|
| December 2024 | Formulation and publication of web accessibility policy |
| December 2024 | Publication of test results conducted in June |
| December 2024 | Update and release of WCAG2.1AA-compliant Medisa Shinyaku corporate website |
| December 2024 | Confirmation of WCAG2.1 conformance for Sawai Pharmaceutical's general information site for medical professionals |
| February 2025 | Confirmation of WCAG2.1 conformance for “SAWAI” lenalidomide capsule product site |
| March 2025 | WCAG2.1AA-compliant zutsu-online site will be released |
| April 2025 | WCAG2.1AA-compliant Sawai Pharmaceutical corporate website will be released |
| FY2025 | WCAG2.1 conformance of the Sawai Pharmaceutical corporate website will be confirmed |
As part of an ongoing effort to improve web accessibility, websites operated by Sawai Group companies will undergo regular testing and the results will be published. We will also focus on guideline establishment and training so that Web accessibility can be addressed from the production stage.
4. Testing Results
FY2024 Web accessibility testing results
Inspection certificate URL https://www.infocreate.co.jp/jis-db/1983/index.htmlOpens in a new window.
5. Standards Unable to Be Attained, Issues Identified and Approach for Addressing Them
- There are some areas where the video subtitles and audio description are insufficient.
- The contrast ratio of the image is insufficient, making the text difficult to distinguish in some places.
- There are some places where alternative text and descriptions of actions, such as images and opening and closing modals, are lacking.
We will continue, through planned page updates, to address these identified issues as they come.
6. Inquiries and Contact Information
Corporate Communications, Sawai Group Holdings Co., Ltd.
Location: 5-2-30 Miyahara, Yodogawa-ku, Osaka
For inquiries, please use the inquiry form on the website.